{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:29:26Z","timestamp":1788607766289,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ejso.2020.10.020","type":"journal-article","created":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T16:56:03Z","timestamp":1602867363000},"page":"188-193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Long-term outcomes for patients with peritoneal acellular mucinosis secondary to low grade appendiceal mucinous neoplasms"],"prefix":"10.1016","volume":"47","author":[{"given":"T.","family":"Evans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Chakrabarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.S.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Malcomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lavelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.T.","family":"O\u2019Dwyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2020.10.020_bib1","doi-asserted-by":"crossref","unstructured":"S. Rout, A.G. Renehan, M.F. Parkinson, M. Saunders, M.S. Wilson, S.T. O\u2019Dwyer, Treatments and outcomes of peritoneal surface tumours through a centralised national service (United Kingdom) Dis Colon Rectum.52:10(1705-1714).","DOI":"10.1007\/DCR.0b013e3181b5504e"},{"key":"10.1016\/j.ejso.2020.10.020_bib2","doi-asserted-by":"crossref","unstructured":"Carr N., Finch J., Ilesley I.C., Chandrakumaran K., Mohamed F., Mirnezami A., et\u00a0al. Pathology and prognosis in pseudomyxoma peritonei: a review of 274 cases. J Clin Pathol 65:919\u2013923.","DOI":"10.1136\/jclinpath-2012-200843"},{"key":"10.1016\/j.ejso.2020.10.020_bib3","doi-asserted-by":"crossref","unstructured":"McDonald J.R., O\u2019Dwyer S.T., Rout S., Chakrabarty B., Sikand K., Fulford P.E., et\u00a0al. Classification of and cytoreductive surgery for low-grade appendiceal mucinous neoplasms. Br J Surg 99:987\u2013992.","DOI":"10.1002\/bjs.8739"},{"key":"10.1016\/j.ejso.2020.10.020_bib4","doi-asserted-by":"crossref","unstructured":"Carr N., Cecil T.D., Mohamed F., L.H.SobinSugarbaker P.H., Gonzalez-Moreno S., et\u00a0al. A consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia. The results of the peritoneal Surface Oncology Group (PSOGI) Modified Delphi Process. Am J Surg Pathol 40(1):14\u201326.","DOI":"10.1097\/PAS.0000000000000535"},{"key":"10.1016\/j.ejso.2020.10.020_bib5","unstructured":"Chua T.C., Moran B.J., Sugarbaker P.H., Levine E.A., Glehen O., Gilly F.N., et\u00a0al. Early and long term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 30:2449\u20132456."},{"key":"10.1016\/j.ejso.2020.10.020_bib6","doi-asserted-by":"crossref","unstructured":"Sugarbaker PH., New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol.7:69-76.","DOI":"10.1016\/S1470-2045(05)70539-8"},{"key":"10.1016\/j.ejso.2020.10.020_bib7","doi-asserted-by":"crossref","unstructured":"Huang Y., Alzahrani N.A., Chua T.C., Govaerts D.L. Morris8. K., Chandrakumaran K., Carr N.J., et\u00a0al. Histological subtype remains a significant prognostic factor for survival outcomes in patients with appendiceal mucinous neoplasm with peritoneal dissemination. Dis Colon Rectum 60:360\u2013367.","DOI":"10.1097\/DCR.0000000000000719"},{"key":"10.1016\/j.ejso.2020.10.020_bib8","doi-asserted-by":"crossref","unstructured":"Govaerts K., Single Centre guidelines for radiological follow-up based on 775 patients treated by cytoreductive surgery and HIPEC for appendiceal Pseudomyxoma peritonei. European Journal of Surgical Oncology.99:1371-1377.","DOI":"10.1016\/j.ejso.2018.06.023"},{"key":"10.1016\/j.ejso.2020.10.020_bib9","doi-asserted-by":"crossref","unstructured":"Bruin S.C., Verwaal V.J., Vincent A., L.J.Van\u2019tVeervan Velthuysen M.F. Clinicopathologic analysis of peritoneal metastases of colorectal and appendiceal origin.Surg. Oncol 17:2330\u20132340.","DOI":"10.1245\/s10434-010-0984-5"},{"key":"10.1016\/j.ejso.2020.10.020_bib10","doi-asserted-by":"crossref","unstructured":"Ronnett B., Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis and relationship to \u2018pseudomyxoma peritonei\u2019.Am J Surg Path. 19:1390-1408.","DOI":"10.1097\/00000478-199512000-00006"},{"key":"10.1016\/j.ejso.2020.10.020_bib11","doi-asserted-by":"crossref","unstructured":"Horvath P., Yurttas C., P.BirkStruller F., Konigsrainer A. Cellularity in low-grade pseudomyxoma peritonei impacts recurrence-free survival following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Langenbeck\u2019s Archives of Surgery 403:985\u2013990.","DOI":"10.1007\/s00423-018-1735-5"},{"key":"10.1016\/j.ejso.2020.10.020_bib12","doi-asserted-by":"crossref","unstructured":"Misdraji J., Yantiss R.K., Graeme-Cook F.M., Balis U.J., Young R.H. Appendiceal Mucinous Neoplasms. a clinipathologic analysis of 107 cases. .Am J Surg Path. 27:1089\u20131103.","DOI":"10.1097\/00000478-200308000-00006"},{"key":"10.1016\/j.ejso.2020.10.020_bib13","doi-asserted-by":"crossref","unstructured":"Shetty S., Natarajan B., Thomas P., Govindarajan V., Sharma P., Loggie B. Proposed classification of Pseudomyxoma peritonei: influence of signet ring cells on survival. American Surgeon 79:1171\u20131176.","DOI":"10.1177\/000313481307901120"},{"key":"10.1016\/j.ejso.2020.10.020_bib14","doi-asserted-by":"crossref","unstructured":"Enblad M., Birgisson H., Wanders A., Skoldberg F., Ghanipour L., Graf W. Importance of absent neoplastic epithelium in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 23:1149\u20131156.","DOI":"10.1245\/s10434-015-4989-y"},{"key":"10.1016\/j.ejso.2020.10.020_bib15","doi-asserted-by":"crossref","unstructured":"Choudry H.A., Pai R.K., Shuai Y., Ramalingam L., Jones H.L., Pingpank J.F., et\u00a0al. Impact of cellularity on oncologic outcomes following cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for pseudomyxoma peritonei. Annals of Surgical Oncology 25:76\u201382.","DOI":"10.1245\/s10434-017-6214-7"},{"key":"10.1016\/j.ejso.2020.10.020_bib16","doi-asserted-by":"crossref","unstructured":"Solomon D., Bekhor E., Leigh N., Maniar Y.M., Totin L., et\u00a0al. Surveillance of low grade appendiceal mucinous neoplasms with peritoneal metastases after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Are 5 years enough? A multi-site Experience. Annals of Surgical Oncology 27:147\u2013153.","DOI":"10.1245\/s10434-019-07678-0"},{"key":"10.1016\/j.ejso.2020.10.020_bib17","doi-asserted-by":"crossref","unstructured":"Horvath P., Yurttas C., P.BirkStruller F., Konigsrainer A. Cellularity in low-grade pseudomyxoma peritonei impacts recurrence-free survival following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Langenbeck\u2019s Archives of Surgery 403:985\u2013990.","DOI":"10.1007\/s00423-018-1735-5"},{"key":"10.1016\/j.ejso.2020.10.020_bib18","doi-asserted-by":"crossref","unstructured":"Baratti D., Kusamura S.K., Milione M., Bruno F., Guaglio M., Deraco M. Validation of the recent PSOGI pathological classification of pseudomyxoma peritonei in a single centre series of 265 patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg oncol 25:404\u2013413.","DOI":"10.1245\/s10434-017-6252-1"},{"key":"10.1016\/j.ejso.2020.10.020_bib19","doi-asserted-by":"crossref","unstructured":"Yantiss R., Shia J., Klimstra D., Hahn H.R, OdzeMisdraji J. Prognostic significance of localised extra-appendiceal mucin deposition in appendiceal mucinous neoplasms. Am J Surg Pathol 33:248\u2013255.","DOI":"10.1097\/PAS.0b013e31817ec31e"},{"key":"10.1016\/j.ejso.2020.10.020_bib20","series-title":"Service report may 2019 highly specialised services (HSS) colorectal and peritoneal Oncology centre the Christie hospital report","year":"2019"},{"key":"10.1016\/j.ejso.2020.10.020_bib21","doi-asserted-by":"crossref","DOI":"10.1007\/s00464-019-07349-x","article-title":"Laparoscopic cytoreductive surgery and Hyperthermic intraperitoneal chemotherapy for perforated low-grade appendiceal mucinous neoplasms","author":"Abudeeb","year":"2020","journal-title":"Surg Endosc."},{"key":"10.1016\/j.ejso.2020.10.020_bib22","doi-asserted-by":"crossref","unstructured":"Sugarbaker P, Peritonectomy procedures. Ann Surg 221:29-42.","DOI":"10.1097\/00000658-199501000-00004"},{"key":"10.1016\/j.ejso.2020.10.020_bib23","doi-asserted-by":"crossref","unstructured":"Harmon R.L., Sugarbaker P.H. Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer. Int Semin Surg Oncol 2:3.","DOI":"10.1186\/1477-7800-2-3"},{"key":"10.1016\/j.ejso.2020.10.020_bib24","doi-asserted-by":"crossref","unstructured":"S.Gonzalez-MorenoGonzalez-Bayon L.A., Ortega-Perez G. Hyperthermic intraperitoneal chemotherapy rationale and technique. World J Gastrointest Oncol 2:68\u201375.","DOI":"10.4251\/wjgo.v2.i2.68"},{"key":"10.1016\/j.ejso.2020.10.020_bib25","doi-asserted-by":"crossref","unstructured":"Dindo D., Demartines N., Clavien P. Classification of surgical complications. A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205\u2013213.","DOI":"10.1097\/01.sla.0000133083.54934.ae"},{"key":"10.1016\/j.ejso.2020.10.020_bib26","series-title":"Follow up guidelines in patients with Pseudomyxoma Peritonei (PMP) after complete cytoreductive surgery","author":"Renehan","year":"2011"},{"key":"10.1016\/j.ejso.2020.10.020_bib27","doi-asserted-by":"crossref","unstructured":"Farquharson A.L., Pranesh N., Witham G., Swindell R., Taylor M.B.A.G. Renehan et.al. A phase II study evaluating the use of concurrent Mitomycin C and Capecitabine in patients with advanced unresectable pseudomyxoma peritonei. Br J Canc 99:591\u2013596.","DOI":"10.1038\/sj.bjc.6604522"},{"issue":"4","key":"10.1016\/j.ejso.2020.10.020_bib28","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1136\/jclinpath-2019-206213","article-title":"Acellular mucin in pseudomyxoma peritonei of appendiceal origin: what is adequate sampling for histopathology","volume":"73","author":"Al-Azzawi","year":"2020","journal-title":"J\u00a0Clin Pathol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798320308532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798320308532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T16:05:40Z","timestamp":1755273940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798320308532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0748798320308532"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2020.10.020","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term outcomes for patients with peritoneal acellular mucinosis secondary to low grade appendiceal mucinous neoplasms","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2020.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2020 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}